Subscribe to Updates for A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Stay informed about the latest developments in this trial. By subscribing, you will receive updates directly to your email. These updates will provide you with important information regarding any changes or progress related to the trial.